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Portrait of a Founder Event, by Behar et al. (p. 487)
Ashkenazi Jews are often highlighted in genetic studies
because of a variety of recessive disorders that are unique
to the population. Also, a great deal of controversy sur-
rounds the issue of which mechanisms are responsible
for the prevalence of these isolated diseases. Some groups
hypothesize that historical conditions favored heterozy-
gotes, and others believe that the cause was rapid popu-
lation expansion following a founding event. As a result,
the maternal history of these people has been the subject
of debate. Behar et al. shed some light on the issue by
using complete mtDNA sequence analysis to identify the
founding lineages of Ashkenazi haplogroups. Their data
support the presence of a founding event in the mater-
nal history of Ashkenazi Jews, with 40% of the modern
Ashkenazi population sharing one of four lineages. The
authors also demonstrate that these four mtDNAs are
not observed in European populations, so it is unlikely
that the lineages were introduced from Europe. Instead,
evidence of these haplogroups in southwestern Asia and
North Africa suggests a Near Eastern ancestry.
Comparison of Phasing Algorithms, by Marchini et al.
(p. 437)
With rapid improvements in genotyping technology fu-
eling a growing interest in performing genomewide as-
sociation studies in large cohorts, it is increasingly nec-
essary to develop methods for efﬁciently handling a large
volume of genotype data. For many disease-mapping en-
deavors as well as evolutionary genetic studies, it is use-
ful to convert disconnected genotypes into phased hap-
lotypes. Because it is cumbersome and expensive to do
this experimentally, a variety of statistical and compu-
tational methods have been developed to predict how
variant alleles are grouped together. Here, Marchini et
al. discuss ﬁve leading phasing algorithms by brieﬂy de-
tailing the mathematical basis of each and outlining their
differences and similarities. Each approach is then ex-
panded to deal with trio data, since they all previously
could be applied only to data from unrelated individuals.
Finally, by evaluating error rates and running time, the
authors compare the algorithms, using simulated data
and real data from the HapMap project. The methods
all perform comparably well, with PHASE having the
lowest error rates.
GNPTAB Mutations in MLII and MLIIIA, by Kudo et
al. (p. 451)
The UDP-N-acetylglucosamine:lysosomal enzyme N-ace-
tylglucosamine-1-phosphotransferase (GlcNAc-phospho-
transferase) is necessary for proper lysosomal trafﬁcking.
A complete loss of GlcNAc-phosphotransferase activity
causes mucolipidosis II (MLII), a severe disease in which
lysosomal targeting and the secretion of lysosomal en-
zymes are affected. The more mild disorders mucolipi-
dosis IIIA (MLIIIA) and mucolipidosis IIIC (MLIIIC) are
caused by decreased or altered enzyme activity. MLIIIA
and MLIIIC are clinically indistinguishable, but a dif-
ferential diagnosis can be made on the basis of the ﬁnd-
ing that, whereas MLIIIA is caused by a general loss of
GlcNAc-phosphotransferase activity, the decreased nor-
mal function of the enzyme in MLIIIC is due not to a
lack of enzyme activity but to aberrant substrate rec-
ognition. GlcNAc-phosphotransferase is assembled from
two subunits, an a/b subunit encoded by the gene GNP-
TAB and a g unit encoded by GNPTG. A great deal
was learned about the functions of these subunits when
it was discovered thatGNPTGmutations causeMLIIIC.
The substrate-recognition function of the enzyme was
then attributed to the g subunit, and it was hypothesized
that the a/b subunit was responsible for the catalytic
activity. It was then predicted that MLII and MLIIIA are
caused by defects in the a/b subunit. Kudo et al. screened
MLII- and MLIIIA-affected families for mutations in
GNPTAB. Truncating mutations that render the enzyme
completely inactive were found in all patients withMLII.
Less severe mutations that retain some activity are found
in patients with MLIIIA.
Telomere QTLs in Healthy Females, by Andrew et al.
(p. 480)
Telomeres, the complexes made up of DNA and protein
at the ends of eukaryotic chromosomes, are crucial for
the maintenance of chromosome architecture and integ-
rity. It is well documented that the length of telomeres
decreases with cell division in vitro, and this shortening
is a factor in replicative senescence in cultured cells. Stud-
ies of donor white blood cells have also demonstrated
that telomeres shorten with age in vivo. There is also
evidence that there is a great deal of variability in telo-
mere length among a population of people of the same
age. Because of the importance of these structures, it is
likely that these interindividual differences might be in-
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volved with susceptibility to certain diseases. Andrew et
al. analyzed the mean telomere length in a large cohort
of unselected, healthy women, to establish the herita-
bility of telomere variation. By using DZ and MZ twins,
they were able to account for common environment ef-
fects and to calculate a narrow heritability estimate of
36%. They followed up these results with a genomewide
scan and identiﬁed a locus on 14q23.3 with signiﬁcant
linkage to telomere length. A suggestive locus was found
on 10q26.13.
KRT5 Mutations in Dowling-Degos Disease, by Betz
et al. (p. 510)
Dowling-Degos disease (DDD), ﬁrst described in 1938,
is an autosomal dominant skin disorder characterized
by disﬁguring hyperpigmentation of the ﬂexures. To date,
the genetic etiology of DDD has been unknown. Betz
et al. performed linkage analysis in two German DDD-
affected pedigrees and identiﬁed a locus on 12q that
overlaps with a cluster of keratin genes. Sequencing of
these genes revealed a frameshift mutation in KRT5 that
segregates with the disease in the families. The authors
then screened eight unrelated patients with DDD and
found that ﬁve carry the same frameshift mutation and
that one has a nonsense mutation. KRT5 is a key com-
ponent of the intermediate ﬁlament cytoskeleton in strat-
iﬁed epithelia. Mutations in KRT5 have also been found
in patients with the more-severe skin disorder epidermo-
lysis bullosa simplex (EBS). In EBS, only missense mu-
tations have been identiﬁed, and it has been shown that
they act in a dominant negative manner. Here, because
of the location of the mutations and the early truncation
of the transcripts, it is presumed that DDD is caused by
loss-of-function variants. This is supported by western-
blot experiments that demonstrate that the frameshift
polypeptide does not incorporate into the cytoskeleton
network at all and remains completely—and aberrant-
ly—in the soluble fraction. Also, microscopy analyses of
skin biopsy samples from patients with the frameshift
mutation reveal structures that closely resemble those of
the patient with the severely truncating nonsense muta-
tion. The identiﬁcation of a KRT5 haploinsufﬁciency
model assists in the development of new hypotheses about
the protein function.
This Month on the Cover
For the ﬁrst half of the 1900s, there was a great deal of
controversy concerning how many chromosomes were
in a normal human cell. For many years, it was believed
that 48 was the correct number, but, in 1956, Tjio and
Levan carefully demonstrated that there are indeed 46.
(Image reproduced with permission from Tjio and Levan
[1956] Hereditas 42:1–6.) The study of human chromo-
somes quickly progressed, and, with so many groups
working in cytogenetics, it became crucial to standardize
the chromosome nomenclature. This task was tackled
by the late Theodore T. Puck (see his obituary, pp. 365–
366 [in this issue]), who was a driving force behind the
Denver Conference (Lancet 1:1063–1065), where the
leaders of the ﬁeld came together to work out a system
for organizing and naming the chromosomes.
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